In English | En español
Questions About Cancer? 1-800-4-CANCER

Find News Releases

Search For:
Between these dates:

All News Releases

NIH study finds regular aspirin use may reduce ovarian cancer risk
NCI Press Release
(Posted: 02/06/2014) - Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health. However, further research is needed before clinical recommendations can be made. The study was published Feb. 6, 2014, in the Journal of the National Cancer Institute.
View the article in Spanish

Dana-Farber researchers find that marker may predict response to ipilimumab in advanced melanoma
NCI Cancer Center News
(Posted: 02/05/2014) - Dana-Farber researchers found that in patients with advanced melanoma using the immunotherapy ipilimumab, presence of higher levels of the protein VEGF in the blood was associated with a poorer response.

University of Michigan scientists find liver tumors in mice exposed to BPA
NCI Cancer Center News
(Posted: 02/04/2014) - A new study shows a significant association between BPA and cancer development.

Stanford chemists develop new technique for improving stomach cancer surgery results
NCI Cancer Center News
(Posted: 02/04/2014) - Chemists and pathologists have collaborated on a method that uses chemical analysis to improve the odds of detecting cancer cells during surgery to prevent patients from needing to return.

Stanford researchers find that oral anti-fungal drug can treat skin cancer in patients
NCI Cancer Center News
(Posted: 02/04/2014) - A new study shows that a common anti-fungal treatment called itraconazole may be useful in treating basal cell carcinoma -- the most common form of skin cancer.

Roswell Park researchers findings on key gene related to cancer metastasis
NCI Cancer Center News
(Posted: 02/04/2014) - Roswell Park researchers report that the loss of these two genes and associated protein products leads to early prostate cancer.

Albert Einstein researchers find that a chemical stem cell signature predicts treatment response for AML
NCI Cancer Center News
(Posted: 02/04/2014) - Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found a chemical “signature” in blood-forming stem cells that predicts whether patients with acute myeloid leukemia will respond to chemotherapy.

Dana-Farber researchers find that revamped radiation treatment schedule for common form of brain cancer can extend survival
NCI Cancer Center News
(Posted: 02/03/2014) - An altered radiation treatment schedule for the most common and lethal form of brain cancer extended survival times, a new study by researchers at Dana-Farber Cancer Institute and other organizations has shown.

USCD scientists find that stem cell signal is linked with cancer growth
NCI Cancer Center News
(Posted: 02/03/2014) - Researchers at the University of California, San Diego School of Medicine have identified a protein critical to hematopoietic stem cell function and blood formation.

Adding chemotherapy following radiation treatment improves survival for adults with a slow-growing type of brain tumor
NCI Press Release
(Posted: 02/03/2014) - Adults with low-grade gliomas, a form of brain tumor, who received chemotherapy following completion of radiation therapy lived longer than patients who received radiation therapy alone, according to long-term follow-up results from a NIH-supported randomized controlled clinical trial. Low-grade gliomas have a more indolent or slower growing behavior and better outcome compared to the more common high-grade gliomas such as glioblastoma. [Image copyright Mayo Clinic, 2012]
View the article in Spanish

< Previous  8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28  Next >